Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
107M
-
Number of holders
-
172
-
Total 13F shares, excl. options
-
89.1M
-
Shares change
-
+11.9M
-
Total reported value, excl. options
-
$1.83B
-
Value change
-
+$246M
-
Put/Call ratio
-
0.13
-
Number of buys
-
102
-
Number of sells
-
-60
-
Price
-
$20.49
Significant Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) as of Q3 2023
203 filings reported holding RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share as of Q3 2023.
ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value per share (RCKT) has 172 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.1M shares
of 107M outstanding shares and own 83.13% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (17.7M shares), WELLINGTON MANAGEMENT GROUP LLP (8.02M shares), MAVERICK CAPITAL LTD (5.63M shares), BlackRock Inc. (5.11M shares), VANGUARD GROUP INC (4.6M shares), WESTFIELD CAPITAL MANAGEMENT CO LP (4.19M shares), STATE STREET CORP (3.14M shares), CITADEL ADVISORS LLC (2.68M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.64M shares), and Logos Global Management LP (1.98M shares).
This table shows the top 172 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.